Research Institute of Molecular Pathology (IMP) is rated 3 out of 5 in the category research. Read and write reviews about Research Institute of Molecular Pathology (IMP). The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology.
Address
Campus-Vienna-Biocenter 1
Company size
201-500 employees